The global surge in the number of cervical cancer patients, especially in developing countries, led to development of new vaccines at a low cost. Most vaccines for cervical cancer are in their late stage of clinical development. For instance, ISA Pharmaceuticals B.V. is focused on manufacturing cervical cancer vaccine, ISA104 ( HPV16) and ISA104 ( HPV16) vaccines is under phase II trial of clinical development.
The global Cervical Cancer Vaccines market size was valued at $ 2,595.4 Mn in 2018 and is projected to reach $ 6 Bn by 2026, growing at a CAGR of 12.1% from 2018 to 2026.
Click Here to Get a Sample Copy (Exclusive Offer: Up to 30% Discount for A Limited Time) @
https://www.coherentmarketinsights.com/insight/request-sample/2931
Growing awareness regarding cervical cancer and increasing rate of unprotected sex in countries such as Swaziland, Malawi, and Zambia are key factors fostering cervical cancer vaccines market growth. For instance, according to the World Cancer Research Fund (WCRF), Swaziland, Malawi, and Zambia are the top 3 countries in cervical cancer incidence. Additionally, cervical cancer can be prevented via widespread immunization with the HPV vaccine, which prevents infection from high-risk HPV strains and also provide protection against the low-risk ones, which cause genital warts.
For instance, according to the Centers for Disease Control and Prevention (CDC), Human papilloma virus vaccines (HPV) can be administered to girls failing in the age group of 11 or 12 years. Moreover, cervical cancer vaccine at an early stage of life is highly effective. For instance, according to the CDC 2016, all teens and adolescents falling between the ages of 9 and 14 should receive two doses of HPV vaccination within a gap of six months.
Growing number of awareness campaigns regarding HPV vaccination by governments and private NGOs is projected to augment the market growth. For instance, in 2013, 1.5 million girls were vaccinated with Gavi (The vaccines Alliance) support. Moreover, in 2017, Gavi helped 30 countries to conduct HPV vaccine demonstration programs.
Key Takeaways of the cervical cancer vaccines market:
The global cervical cancer vaccines market is expected to witness a CAGR of 12.1% during the forecast period (2019–2026), due to growing awareness regarding cervical cancers and increasing rate of unprotected sex.
Among product type, the Gardasil 9 segment is expected to account for a major revenue share in 2026. According to The Advisory Committee on Immunization Practices (ACIP) 2016, Gardasil 9 is the only HPV vaccine available in the U.S. and is recommended for vaccinating girls and boys between 11 and 12 years of age, before they become sexually active. Moreover, ACIP recommends an immunization schedule of two doses before the age of 14 and three doses after the age 14.
Major players operating in the global cervical cancer vaccines market include, GlaxoSmithKline PLC and Merck & Co. Inc.
The Study Objectives are:
✔ A comprehensive insight into key players operating in the Cervical Cancer Vaccines Market and their corresponding data.
✔ It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
✔ Regional analysis, which includes insight into the dominant market and corresponding market share.
✔ It also includes various socio-economic factors affecting the evolution of the market in the region.
✔ The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/2931
Table of Contents:
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Landscape
- Product Recall
- Epidemiology Analysis
- Technology Overview
- PEST Analysis
- Porter’s Five Forces Model
- Market Dynamics
- Global Cervical Cancer Vaccines Market , By Product Type, 2019 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Gardasil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Gardasil 9
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Cervarix
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Introduction
- Global Cervical Cancer Vaccines Market, By Distribution Channel, 2018 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Government Entities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
- Introduction
- Global Cervical Cancer Vaccines Market, By Region, 2018 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, By Region, 2017 – 2026
- Regional Trends
- North America
- Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel 2018 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
- Market Size and Forecast, Distribution Channel, 2018 – 2026, (US$ Million)
- Market Size and Forecast, By Country/Region, 2018 – 2026, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Company Profiles
- GlaxoSmithKline plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Merck & Co. Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- GlaxoSmithKline plc.
- Analyst Views
- Company Profiles
- Section
- References
- Research Methodology
- About Us and Sales Contact
Customization of the Report
Our research analysts will help you to get customized details for your report, which can be modified in terms of a specific region, application or any statistical details. In addition, we are always willing to comply with the study, which triangulated with your own data to make the market research more comprehensive in your perspective.
About us:
Coherent Market Insights is a global market intelligence and consulting firm that offers syndicated and customised research reports as well as consulting services. We’re known for our actionable insights and reliable reports in a wide range of industries, including aerospace and defence, agriculture, food and beverage, automotive, chemicals and materials, and virtually every other domain and sub-domain imaginable. Our clients benefit from our highly reliable and accurate reports. We’re also committed to continuing to provide measurable, long-term results for our clients after COVID-19 by playing a leading role in providing insights into various sectors.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837